Heart failure nyha class II

This study tested a new way to manage heart failure using a small heart monitor (Reveal LINQ) and a special algorithm. The goal was to see if this approach could safely guide treatment and improve outcomes for people with moderate heart failure. 826 participants with NYHA class I…

This completed study tested whether adding sildenafil to dapagliflozin helps heart failure patients who also have high blood pressure in their lungs. 100 participants received either dapagliflozin alone or both drugs. Researchers measured changes in heart pumping strength and lun…

This study tested whether a special type of heart MRI, called T1 mapping, can accurately diagnose cardiac amyloidosis—a condition where abnormal proteins build up in the heart muscle. Researchers studied 112 older adults with heart failure and thickened heart walls. They compared…

This study tests two treatments—blood flow restricted resistance exercises and low-level laser therapy—to see if they improve heart function in people with chronic heart failure. Sixty patients aged 40-60 with mild heart failure will be assigned to one of the treatments for 12 we…

This study tested a modified pacemaker in 34 people with heart failure (NYHA class II or III). The device delivers special pacing signals to reduce overactive sympathetic nerve activity, which can strain the heart. Researchers measured changes in arterial elastance, a sign of rel…